We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$490M
AUM Growth
-$143M
Cap. Flow
-$164M
Cap. Flow %
-33.56%
Top 10 Hldgs %
10.5%
Holding
855
New
346
Increased
61
Reduced
95
Closed
352

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.22M
2
META icon
Meta Platforms (Facebook)
META
+$6.1M
3
BSX icon
Boston Scientific
BSX
+$5.72M
4
ACN icon
Accenture
ACN
+$5.66M
5
EXPE icon
Expedia Group
EXPE
+$4.52M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$14.8M
2
ORCL icon
Oracle
ORCL
+$10.3M
3
DIS icon
Walt Disney
DIS
+$9.89M
4
AAPL icon
Apple
AAPL
+$9.74M
5
WFC icon
Wells Fargo
WFC
+$8.86M

Sector Composition

Rank Sector Weight
1 Technology 26.64%
2 Consumer Discretionary 16.12%
3 Healthcare 15.86%
4 Industrials 12.65%
5 Financials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVTC icon
326
Evertec
EVTC
$1.94B
$400K 0.08%
+11,837
New +$413K
REAL icon
327
The RealReal
REAL
$1.44B
$400K 0.08%
+37,600
New +$278K
EME icon
328
Emcor
EME
$31.4B
$398K 0.08%
+613
New +$372K
FTDR icon
329
Frontdoor
FTDR
$5.22B
$397K 0.08%
5,900
-15,200
-72% -$925K
GEV icon
330
GE Vernova
GEV
$251B
$396K 0.08%
+644
New +$390K
SKT icon
331
Tanger
SKT
$4.84B
$396K 0.08%
+11,700
New +$381K
RGEN icon
332
Repligen
RGEN
$8.2B
$394K 0.08%
+2,948
New +$358K
RARE icon
333
Ultragenyx Pharmaceutical
RARE
$2.56B
$394K 0.08%
+13,100
New +$393K
CGNX icon
334
Cognex
CGNX
$10B
$388K 0.08%
+8,571
New +$347K
ALLY icon
335
Ally Financial
ALLY
$13.4B
$388K 0.08%
+9,898
New +$397K
ZTS icon
336
Zoetis
ZTS
$32.5B
$380K 0.08%
+2,600
New +$393K
NVST icon
337
Envista
NVST
$4.39B
$379K 0.08%
18,600
-45,600
-71% -$937K
ELAN icon
338
Elanco Animal Health
ELAN
$12.7B
$379K 0.08%
18,800
-92,100
-83% -$1.54M
DEO icon
339
Diageo
DEO
$49.4B
$378K 0.08%
+3,956
New +$415K
PL icon
340
Planet Labs
PL
$7.28B
$375K 0.08%
28,897
-76,800
-73% -$592K
AI icon
341
C3.ai
AI
$1.38B
$375K 0.08%
21,600
-30,600
-59% -$639K
CZR icon
342
Caesars Entertainment
CZR
$6.1B
$374K 0.08%
+13,857
New +$375K
MTCH icon
343
Match Group
MTCH
$9.16B
$374K 0.08%
+10,600
New +$378K
SNN icon
344
Smith & Nephew
SNN
$13.7B
$374K 0.08%
+10,300
New +$355K
AMD icon
345
Advanced Micro Devices
AMD
$741B
$372K 0.08%
+2,300
New +$371K
FITB
346
Fifth Third Bancorp
FITB
$52.4B
$371K 0.08%
+8,318
New +$364K
GFS icon
347
GlobalFoundries
GFS
$26.9B
$370K 0.08%
10,319
+4,819
+88% +$172K
SMCI icon
348
Super Micro Computer
SMCI
$18.4B
$369K 0.08%
+7,700
New +$368K
HPQ icon
349
HP
HPQ
$25.9B
$368K 0.08%
+13,500
New +$360K
FRSH icon
350
Freshworks
FRSH
$3.09B
$367K 0.08%
31,207
+8,600
+38% +$116K

Similar funds

Bayesian Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Bayesian Capital Management held 855 positions worth $490M, down 23% from $633M the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Bayesian Capital Management withdrew a net $164M in Q3 2025, closing 352 positions and reducing 95 holdings. Its most notable exit was Nike, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Microsoft worth $6.32M.

  • Bayesian Capital Management's largest Q3 2025 buy was Microsoft: 12,200 shares worth $6.32M.
  • Bayesian Capital Management added most to Idexx Laboratories in Q3 2025, an estimated $3.81M increase.
  • Bayesian Capital Management's biggest Q3 2025 reduction was Walt Disney, cutting an estimated $9.89M.
  • Bayesian Capital Management fully exited Nike in Q3 2025, selling an estimated $14.8M.
  • Bayesian Capital Management's ten largest holdings make up 10% of its $490M portfolio in Q3 2025.
  • Bayesian Capital Management opened 346 new positions and closed 352 in Q3 2025.
  • Bayesian Capital Management's portfolio value fell 23% quarter-over-quarter to $490M.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.